Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2011

Feb 16, 2011

30016_dirs_2011-02-16_795b052f-5dd1-4b20-b55d-7038d4f03091.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-02-14

Reporting Person: Williams Michael J PhD (Corporate Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-14 Common Stock M 274 Acquired 9418 Direct
2011-02-14 Common Stock M 476 Acquired 9894 Direct
2011-02-14 Common Stock M 343 Acquired 10237 Direct
2011-02-14 Common Stock M 400 Acquired 10637 Direct
2011-02-14 Common Stock M 399 Acquired 11036 Direct
2011-02-14 Common Stock F 632 $77.59 Disposed 10404 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-14 Non-Qualified Stock Option (right to buy) $77.59 A 10716 Acquired 2018-02-13 Common Stock (10716) Direct
2011-02-14 Incentive Stock Option (right to buy) $77.59 A 1288 Acquired 2018-02-13 Common Stock (1288) Direct
2011-02-14 Restricted Stock Unit $ A 1289 Acquired Common Stock (1289) Direct
2011-02-14 Restricted Stock Unit $ M 274 Disposed Common Stock (274) Direct
2011-02-14 Restricted Stock Unit $ M 476 Disposed Common Stock (476) Direct
2011-02-14 Restricted Stock Unit $ M 343 Disposed Common Stock (343) Direct
2011-02-14 Restricted Stock Unit $ M 400 Disposed Common Stock (400) Direct
2011-02-14 Restricted Stock Unit $ M 399 Disposed Common Stock (399) Direct

Footnotes

F1: Incudes 66 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2010.

F2: Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on each of 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,112 shares on 02/14/2016.

F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2016) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2007) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F9: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.